How Anastrozole Affects Estradiol

Anastrozole is a non-steroidal, competitive aromatase inhibitor that binds reversibly to the CYP19A1 (aromatase) enzyme.

How it works:

• Aromatase converts androgens (testosterone, androstenedione) to estrogens (estradiol, estrone)
• Anastrozole competitively blocks the active site of aromatase, preventing this conversion
• At standard doses, it reduces circulating estradiol by approximately 70-85%
• The inhibition is reversible: once anastrozole is discontinued, aromatase activity returns to normal within days

Pharmacokinetics relevant to bodybuilders:

• Half-life: approximately 46 hours, allowing for twice-weekly dosing
• Reaches steady state in about 7 days
• Unlike exemestane (a suicidal inhibitor), anastrozole does not permanently inactivate aromatase molecules. This means a missed dose can result in a rebound effect as accumulated substrate is rapidly converted.

Low-dose (0.25 mg twice weekly):

• Reduces estradiol by approximately 40-60%
• Suitable for most TRT patients who need modest estrogen control
• A pre-AI estradiol of 50 pg/mL might drop to 20-30 pg/mL

Standard dose (0.5 mg twice weekly):

• Reduces estradiol by approximately 60-80%
• Appropriate for men with high body fat or higher testosterone doses
• Risk of over-suppression increases at this dose

Higher doses (1 mg three times weekly or more):

• Can reduce estradiol to near-undetectable levels (below 5 pg/mL)
• Commonly seen in misguided bodybuilding protocols
• Causes severe symptoms: joint pain, fatigue, depression, sexual dysfunction, bone loss

Important: Response varies significantly between individuals. Genetics (CYP19A1 polymorphisms), body fat percentage, and testosterone dose all influence how much estradiol reduction a given AI dose produces.

Before starting an AI: Confirm that estradiol is genuinely elevated with the sensitive assay (LC-MS/MS). Do not start an AI based on symptoms alone or based on the standard immunoassay.

After starting or adjusting dose: Recheck sensitive estradiol 4-6 weeks after any change. This is critical to avoid over-suppression.

Target range: Most clinicians aim for 20-35 pg/mL on the sensitive assay, though individual symptom response matters more than a specific number.

Ongoing monitoring: Once stable, check estradiol with each regular blood panel (every 3-6 months).

Red flags for over-suppression: Joint pain (especially knees, shoulders, elbows), low libido, dry skin, fatigue, depression, irritability. If these appear, check estradiol urgently.

Starting an AI:

• Always start with the lowest dose: 0.25 mg twice weekly
• Do not start an AI prophylactically; wait for confirmed elevated estradiol with symptoms
• Many TRT patients never need an AI if their dose and injection frequency are optimised

Dose titration:

• Adjust in 0.25 mg increments
• Wait 4-6 weeks between adjustments to reach steady state
• If estradiol drops below 15-20 pg/mL, reduce or stop the AI

If estradiol is crashed (below 10-15 pg/mL):

• Stop anastrozole immediately
• Estradiol typically recovers within 3-7 days due to the reversible mechanism
• Do not restart until estradiol has normalised and only at a lower dose
• Consider whether you truly need an AI or whether dose/frequency adjustment could suffice

Alternatives to consider before using an AI:

• Increase injection frequency (lowers peak testosterone, reduces aromatisation)
• Reduce testosterone dose
• Lose body fat (reduces aromatase activity)
• DIM (200-300 mg/day) and calcium D-glucarate (500-1500 mg/day) for mild estrogen modulation